Sanctuary Advisors LLC Acquires Shares of 44,941 IonQ, Inc. $IONQ

Sanctuary Advisors LLC bought a new stake in shares of IonQ, Inc. (NYSE:IONQ - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 44,941 shares of the company's stock, valued at approximately $2,394,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Royal Bank of Canada boosted its holdings in IonQ by 12.5% in the first quarter. Royal Bank of Canada now owns 134,176 shares of the company's stock valued at $2,962,000 after purchasing an additional 14,898 shares during the last quarter. Amundi purchased a new stake in IonQ during the 1st quarter worth approximately $630,000. AQR Capital Management LLC raised its position in shares of IonQ by 106.2% in the 1st quarter. AQR Capital Management LLC now owns 57,305 shares of the company's stock valued at $1,265,000 after purchasing an additional 29,513 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of IonQ by 24.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 450,031 shares of the company's stock valued at $9,932,000 after purchasing an additional 87,428 shares in the last quarter. Finally, Focus Partners Wealth boosted its stake in shares of IonQ by 30.3% during the 1st quarter. Focus Partners Wealth now owns 46,782 shares of the company's stock valued at $1,032,000 after buying an additional 10,881 shares during the last quarter. 41.42% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at IonQ

In related news, Director Kathryn K. Chou sold 2,757 shares of the firm's stock in a transaction dated Thursday, June 18th. The stock was sold at an average price of $55.02, for a total transaction of $151,690.14. Following the completion of the transaction, the director owned 62,608 shares of the company's stock, valued at $3,444,692.16. This trade represents a 4.22% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Gabrielle B. Toledano sold 2,757 shares of the firm's stock in a transaction dated Thursday, June 18th. The shares were sold at an average price of $55.01, for a total transaction of $151,662.57. Following the transaction, the director owned 11,154 shares of the company's stock, valued at approximately $613,581.54. This trade represents a 19.82% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 9,329 shares of company stock valued at $513,216. 0.55% of the stock is owned by corporate insiders.

IonQ Trading Up 2.4%

Shares of NYSE IONQ opened at $42.06 on Wednesday. IonQ, Inc. has a 12-month low of $25.89 and a 12-month high of $84.64. The company has a market cap of $16.03 billion, a price-to-earnings ratio of -9.03 and a beta of 3.28. The stock's 50 day simple moving average is $43.68 and its 200 day simple moving average is $43.27.

IonQ (NYSE:IONQ - Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The company reported ($0.33) earnings per share for the quarter, beating the consensus estimate of ($0.56) by $0.23. IonQ had a negative net margin of 553.27% and a negative return on equity of 22.29%. The firm had revenue of $80.05 million for the quarter, compared to the consensus estimate of $66.47 million. During the same period last year, the firm posted ($0.70) EPS. IonQ's quarterly revenue was up 286.7% compared to the same quarter last year. As a group, equities analysts forecast that IonQ, Inc. will post -2.86 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have recently weighed in on IONQ shares. Wall Street Zen downgraded shares of IonQ from a "sell" rating to a "strong sell" rating in a research report on Saturday, August 8th. Benchmark reiterated a "buy" rating and set a $60.00 price objective on shares of IonQ in a research note on Thursday, August 6th. Rosenblatt Securities reissued a "buy" rating and set a $100.00 price objective on shares of IonQ in a report on Thursday, August 6th. Morgan Stanley set a $49.00 target price on shares of IonQ in a research report on Thursday, August 6th. Finally, Jefferies Financial Group set a $75.00 target price on shares of IonQ in a research note on Thursday, August 6th. Nine equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $69.92.

IonQ News Roundup

Here are the key news stories impacting IonQ this week:

• Positive Sentiment: The Federal Trade Commission ended its review of IonQ’s proposed acquisition of SkyWater Technology, removing a regulatory overhang. The decision may improve confidence that the transaction can proceed, while highlighting the strategic importance of domestic semiconductor and quantum-computing inputs. FTC Drops IonQ / SkyWater Merger Review
• Positive Sentiment: IonQ appointed technology-finance expert Dr. Eric Ball and former SkyWater chairman and Samsung North America CEO Timothy Baxter to its board. Their experience could support the SkyWater integration, capital allocation and the company’s expansion into semiconductor and infrastructure markets. IonQ Appoints Dr. Eric Ball and Timothy Baxter to Board
• Positive Sentiment: IonQ’s Skyloom subsidiary reported that its optical-communications network reached 84 on-orbit terminals after additional deployments supporting satellites associated with the U.S. Space Development Agency. The milestone reinforces IonQ’s diversification into secure space communications and defense technology. IonQ’s Skyloom Optical Communications Terminals Reach 84 On-Orbit Installations
• Positive Sentiment: Recent coverage emphasized IonQ’s rapid revenue growth, merchant-supplier strategy and broader photonics, networking and semiconductor capabilities. Its latest reported quarter showed revenue up 286.7% year over year to $80.1 million, exceeding estimates, which supports the investment case that IonQ is becoming more than a quantum-computer developer. How IonQ Is Growing Its Merchant Supplier Role in Quantum Space
• Neutral Sentiment: Strong performance by the Defiance Quantum ETF and continued investor interest in quantum stocks may provide favorable sector-wide momentum for IONQ, although ETF flows do not necessarily reflect IonQ-specific fundamentals. That Quantum Fund Is Up 40% in 2026
• Negative Sentiment: Analysts continue to flag valuation and profitability risks. IonQ remains loss-making, with a negative net margin and expectations for a full-year loss, while comparisons with Rigetti, Quantum Computing Inc. and D-Wave highlight the uncertainty surrounding commercialization and long-term cash flow. IonQ Stock May Be Rich On Book Value Yet Strong On Returns

About IonQ

IonQ, Inc engages in the development of general-purpose quantum computing systems in the United States. It sells access to quantum computers of various qubit capacities. The company makes access to its quantum computers through cloud platforms, such as Amazon Web Services (AWS) Amazon Braket, Microsoft's Azure Quantum, and Google's Cloud Marketplace, as well as through its cloud service. It also provides contracts associated with the design, development, and construction of specialized quantum computing hardware systems; maintenance and support services; and consulting services related to co-developing algorithms on quantum computing systems.

Want to see what other hedge funds are holding IONQ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IonQ, Inc. (NYSE:IONQ - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source